At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
Ileal Interposition with Sleeve Gastrectomyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Interventional Study of Effects of Ileal Interposition With Sleeve Gastrectomy for Control of Type 2 Diabetes
In Brief
A clinical study evaluating Ileal Interposition with Sleeve Gastrectomy for Diabetes. Completed, enrolled 30 participants across 1 site.
Detailed Summary
Ileal interposition shifts a segment of ileum proximally to achieve maximal meal stimulated Glucagon-Like Peptide-1 secretion and coupled with a limited/complete sleeve gastrectomy (depending on the Body Mass Index), for Ghrelin reduction, helps in achieving good glycemic control in Type 2 Diabetes patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesIndia
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJan 2008
First PostedFeb 2009
Primary CompletionMay 2010
Study CompletionMay 2011
TodayJul 2026
First PostedFeb 3, 2009
Enrollment StartJan 1, 2008
Primary CompletionMay 1, 2010
Study CompletionMay 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 17.4 years ago
Interventions
Ileal Interposition with Sleeve Gastrectomyprocedure
Transposition of a segment of Ileum proximally coupled with limited /complete sleeve gastrectomy.